Home > News By Companies > AMERSHAM BIOSCIENCES

Emailwire Feed emailwire JavaScript emailwire XML

Amersham Biosciences' IN Cell Analyzer Delivers Outstanding Results for AstraZeneca

(EMAILWIRE.COM, June 19, 2002 ) Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM) today announced that its IN Cell Analyzer system for cellular screening is delivering outstanding results for U.K.-based global pharmaceutical company AstraZeneca, one of the system's...more

Video Release





Private Equity, Angel Investing


Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International



Equityallianceir.com

 






Satellite TV for PC


Watch Streaming Tv Right on Your PC




Satellitetelevisionforpc.com
 

 




 



Your text Ads & 

PR


 
Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. 




Read more on Text Ads & PR
 

 







Your text Ads Here!


 
Text Ads are only $289 per month. Ads are placed same day. 




More 

on Text Ads Advertising
 

 







 











 

 

Press Release
 Resources



Benefits of Online Press Release Distribution Service

Press Releases

Press Release Examples

Press Release Format

Press Release Free

Press Release Service Comparison

Press Release Writing

Press release Writing Tips